Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Novopharm Biotech completes patient enrollment for phase I study of NOVOMAb-G2

Nov. 23, 1998

New U.S. patent provides protection for improved Avicine formulations

Nov. 20, 1998

Vical provides clinical update of Allovectin-7 in treatment of head and neck cancer

Nov. 18, 1998

Study shows Zadaxin plus chemotherapy inhibits cancerous tumors in mice

Nov. 18, 1998

New Maxamine data to be presented at annual symposium

Nov. 18, 1998

Protein Design Labs grants patent license to Genentech

Nov. 16, 1998

Axis Genetics and Biomira collaborate on the development of a cancer vaccine

Nov. 16, 1998

AltaRex seeks permission to study immunological activity of OvaRex in phase II trial

Nov. 11, 1998

AltaRex moves to conduct clinical trial with OvaRex in more advanced ovarian cancer

Nov. 6, 1998

Adoptive immunotherapy of cancer with HSPs covered by U.S. patent

Nov. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...